DE
53
8
HSIC
50
-3
NEM
48
2
RCL
76
2
INTC
43
6
PCG
80
3
R
66
-4
DNB
50
-4
FOXA
48
7
FCX
53
-5
PG
51
3
C
60
-2
SWN
77
4
MS
64
7
AMP
66
-4
NTAP
60
2
JBHT
50
-6
EMN
70
-2
GPC
37
-14
OMC
64
-2
DE
53
8
HSIC
50
-3
NEM
48
2
RCL
76
2
INTC
43
6
PCG
80
3
R
66
-4
DNB
50
-4
FOXA
48
7
FCX
53
-5
PG
51
3
C
60
-2
SWN
77
4
MS
64
7
AMP
66
-4
NTAP
60
2
JBHT
50
-6
EMN
70
-2
GPC
37
-14
OMC
64
-2
Financhill
Back

Amplify Natural Resources DivETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

NDIV
Amplify Natural Resources DivETF

Last Price:
28.80
Seasonality Move:
2.46%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
50
Amplify Natural Resources DivETF (NDIV) is a Sell

Is Amplify Natural Resources DivETF a Buy, Sell or Hold?

  • The current Amplify Natural Resources DivETF [NDIV] share price is $28.51. The Score for NDIV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • NDIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NDIV Stock Price Chart

What is Amplify Natural Resources DivETF's stock price today?

  • The Amplify Natural Resources DivETF share price today is $28.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NDIV is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

NDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 50.08 Buy
Chaikin Money Flow: -713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.18 - 29) Sell
Bollinger Bands (100): (28.3 - 29.34) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

NDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.38 Buy
20-day SMA: 28.55 Sell
50-day SMA: 28.67 Sell
200-day SMA: 28.25 Buy
8-day EMA: 28.46 Buy
20-day EMA: 28.47 Buy
50-day EMA: 28.59 Sell
200-day EMA: 28.22 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Amplify Natural Resources DivETF Earnings Growth & NDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Amplify Natural Resources DivETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):